Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1
Other1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
Bacterial PneumoniaCOVID-19Pneumonia Due to H. Influenzae+5 more
StudydirectorStart date: 2020-10-01
NCT02139163Recruiting
Epidemiological Study on Community Acquired Pneumonia
Community Acquired Pneumonia
Studychair

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Martin Witzenrath, Prof. Dr.

Charité - Universitaetsmedizin Berlin

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Capnetz StiftungDeutsches Zentrum für Lungenforschung e. V.
Collaborated on 1 trial
Similarity Score14%

Jessica Rademacher, Prof. Dr.

Medical School Hannover

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Capnetz StiftungDeutsches Zentrum für Lungenforschung e. V.
Collaborated on 1 trial
Similarity Score14%

Mathias W. R. Pletz, Prof. Dr.

University Hospital Jena

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Capnetz StiftungDeutsches Zentrum für Lungenforschung e. V.
Collaborated on 1 trial
Similarity Score14%

Gernot G. U. Rohde, Prof. Dr.

University Hospital Giessen and Marburg

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Capnetz StiftungDeutsches Zentrum für Lungenforschung e. V.
Collaborated on 1 trial
Similarity Score14%

Jan Rupp, Prof. Dr.

University Hospital Schleswig-Holstein

Related
1 trials

Shared therapeutic areas:

Community-Acquired Pneumonia

Worked with same sponsors:

Capnetz StiftungDeutsches Zentrum für Lungenforschung e. V.
Collaborated on 1 trial
Similarity Score14%

Mikhail Samsonov

R-Pharm

Related
34 trials

Shared therapeutic areas:

COVID-19Pneumonia, Bacterial
Similarity Score7%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Wenhong Zhang, MD

Huashan Hospital

Related
4 trials

Shared therapeutic areas:

COVID-19
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04952337StudyDirector

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)

Bacterial PneumoniaCOVID-19Pneumonia Due to H. Influenzae+5 more
Unknown
NCT02139163StudyChair

Epidemiological Study on Community Acquired Pneumonia

Community Acquired Pneumonia
Recruiting

All 2 trials loaded